Vietnam: Ban from Ministry of Health vs. Piloting Management from Ministry of Industry and Commerce

Regulations by 2FIRSTS, edited by Sophia
May.05.2024
Vietnam: Ban from Ministry of Health vs. Piloting Management from Ministry of Industry and Commerce
Vietnam debates whether to ban or regulate e-cigarettes due to potential health risks and widespread use among youth.

According to Vietnamese media outlet Viettimes, on May 4th, the issue of whether to ban or regulate e-cigarettes was discussed in the National Assembly by the Social Affairs Committee and the National Assembly's Committee on Cultural Education to address concerns about the harm caused by e-cigarettes and heated tobacco products.

 

Deputy Minister of Health Dao Honglan stated that the Ministry of Health has already done a lot of work, providing advice to the national management through evidence and impact assessment in order to revise the Tobacco Harmful Effects Law and make plans. Minister of Industry and Trade Pan Sheng proposed piloting management of e-cigarettes.

 

Faced with the conflicting views of the Ministry of Health and the Ministry of Industry and Commerce on e-cigarettes, representatives in Congress raised pointed questions.

 

The Vice Chairman of the Vietnamese National Assembly, Tran Thanh Man, expressed concerns about the increasing prevalence of e-cigarette use, especially among young people, teenagers, and students, which are gradually replacing traditional tobacco. He emphasized that the health risks of e-cigarettes are similar to traditional tobacco, particularly the harm they pose to the brain development of children and adolescents, leading to addiction, cognitive and emotional disorders, reduced learning abilities, and psychological obstacles. E-cigarettes also have a negative impact on the quality of human resources, affecting social order and economic and social development.

 

Vice Chairperson of the Cultural and Education Committee, Ms. Ruan Mei, calls for clarity on the boundaries between the economic benefits of e-cigarettes and the negative impacts on health costs.

 

Speaking at the conference, Dr. Nguyen Vinh Chi firmly stated, "I find it strange, why test addictive substances, especially such deadly substances. There is absolutely no need for any testing! Because e-cigarettes have already proliferated globally and in Vietnam, their harm is widely recognized... As a doctor, I question whether anyone can find any benefits of this e-cigarette!"

 

Dao Honglan emphasized that e-cigarettes and heated tobacco products pose great risks to human health, and therefore should be banned from the start rather than being allowed on the market before becoming unmanageable. Even with the various current methods of e-cigarette regulation, the question of whether they can be effectively managed is a concerning issue. Who will be responsible for people's lives? Especially when around 40,000 people die from smoking each year.

 

Deputy Director Chen Ruanquan, of the Legal and Administrative Reform Department of the Ministry of Public Security, shares the same view as the Ministry of Health, believing that e-cigarettes pose a harm to human health, particularly for young people. He maintains that this product not only harms human health but also the economy. In particular, individuals who have been convicted of drug offenses are increasingly using e-cigarettes to soak and mix drugs.

 

Teenage use of e-cigarettes is widespread. People are always seen using e-cigarettes while waiting at red lights on the streets. This trend is growing at a concerning rate, so the harms of e-cigarettes outweigh the expected economic and social benefits, according to Rear Admiral Chen Ruanquan.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Australia Adds 6-Methylnicotine to Schedule 9 Prohibited Substances, Effective October 1
Australia Adds 6-Methylnicotine to Schedule 9 Prohibited Substances, Effective October 1
Australia's Therapeutic Goods Administration published a final decision on September 25 to classify 6-methylnicotine as a Schedule 9 prohibited substance under the Poisons Standard, effective October 1, 2026. TGA said the chemical has been reported in e-cigarette liquids sold in Australia and marketed as nicotine-free or nicotine alternatives, while evidence also indicates its use in preparations such as oral pouches. The government originally proposed a Schedule 7 classification but ultimately adopted the stricter Schedule 9 designation, citing acute toxicity, dependence risk, use in unapproved consumer products and misleading marketing.
News
Sep.29 by 2Firsts Perspectives
NAS 2026 | Former FDA Tobacco Chief Mitch Zeller Calls for Shift From “End Game” to “End State”
NAS 2026 | Former FDA Tobacco Chief Mitch Zeller Calls for Shift From “End Game” to “End State”
At the 2026 New Approaches Summit in New York, former FDA Center for Tobacco Products Director Mitch Zeller called for the tobacco harm reduction debate to shift from the traditional “end game” toward defining a desired “end state.” He also highlighted unresolved concerns around dual use, argued that biomarkers of exposure may be more meaningful than cigarettes-per-day in assessing risk reduction, and said nicotine misperceptions remain a major barrier to public health progress.
Sep.25
Elf Bar Vape Explosion and Amputation Claim Spurs Coverage Suit, U.S. Insurer MUSIC Seeks Ruling It Owes No Duty to Defend or Indemnify Distributor i5
Elf Bar Vape Explosion and Amputation Claim Spurs Coverage Suit, U.S. Insurer MUSIC Seeks Ruling It Owes No Duty to Defend or Indemnify Distributor i5
Mesa Underwriters Specialty Insurance Company has asked a federal court in Washington to declare that it has no duty to defend or indemnify vape distributor i5 Distribution in a product liability case involving an Elf Bar BC5000. The plaintiff alleges that the disposable vape caught fire and exploded in his pocket, causing severe burns and ultimately requiring an above-the-knee amputation of his left leg. MUSIC is relying on a tobacco, nicotine or nicotine replacement products exclusion and a premises limitation endorsement. The court has not ruled on the coverage dispute.
News
Sep.10
Global Nicotine-Pouch E-Commerce Group Haypp Shuts Sweden’s Snusnetto Over Age Verification as Identity Checks Become Industry Infrastructure for New Nicotine Products
Global Nicotine-Pouch E-Commerce Group Haypp Shuts Sweden’s Snusnetto Over Age Verification as Identity Checks Become Industry Infrastructure for New Nicotine Products
Sweden's Supreme Administrative Court has declined to hear an appeal over age verification for tobacco and nicotine products collected from parcel lockers, leaving in place a lower-court ruling that geo-located BankID verification is insufficient to securely verify the actual recipient. Haypp Group has stopped tobacco and nicotine sales through Snusnetto and is deploying a new system across its other Swedish e-commerce sites to verify the age of the person who actually opens the locker and receives the shipment. The change comes as age verification across next-generation nicotine products expands from purchase checks into retail, delivery and, for some e-cigarettes, device access itself.
Regulations
Oct.20
Australia Tobacco Tax Debate Spreads Within Labor as NSW Premier Minns Reaffirms Support for a Cut
Australia Tobacco Tax Debate Spreads Within Labor as NSW Premier Minns Reaffirms Support for a Cut
Australia’s tobacco excise debate is increasingly exposing differences within the governing Labor Party. New South Wales Labor Premier Chris Minns reaffirmed on September 8 that he supports reducing tobacco excise, arguing that current tax settings are pushing consumers toward cheaper black-market cigarettes. Federal Health Minister Mark Butler continues to oppose an excise cut, while Treasurer Jim Chalmers and Assistant Treasurer Daniel Mulino have recently stopped short of ruling out future changes. The divergence follows the opposition Coalition’s proposal to cut tobacco excise by 80%.
Sep.08
Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Eleftheria (Ria) Kioupritzi, a biopharmaceutical professional with more than 15 years of experience, has joined Philip Morris International as Director Scientific Affairs within Corporate Affairs. She previously served at Roche as Senior Scientific Communications Director for Neuroscience and Rare Diseases and worked extensively in spinal muscular atrophy. Her earlier career also covered competitive intelligence, clinical and regulatory monitoring, pipeline development and launch preparation. During her time working in Roche's SMA field, Evrysdi passed through several U.S. FDA milestones, including its initial approval, an expanded indication for younger infants and approval of a tablet formulation. Public records do not show that Kioupritzi herself led the FDA submissions.
Sep.22